An entrepreneur, scientist and engineer, she enjoys working at the interface of business, technology and biology to deliver improved therapies to patients. She co-founded AbCellera, a Canadian biotechnology company focused on the discovery of therapeutic antibodies from natural immune repertoires. Engaged in partnerships to develop next-generation antibodies, AbCellera recently announced its collaboration with global healthcare company Novartis. Earlier this year, AbCellera signed an agreement with the Bill and Melinda Gates Foundation to fight infectious disease and accelerate global health research. In 2017, AbCellera won the LifeSciences BC Growth Stage Company of the Year Award.

Share This